Kyri K. Van Hoose
Equibles does not estimate personal net worth.
Get an email with a short summary when Dermata Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DRMA alertsAbout Kyri K. Van Hoose
Kyri K. Van Hoose is recorded as CFO at Dermata Therapeutics, Inc. (DRMA). The newest filing on record that lists Kyri K. Van Hoose as CFO at Dermata Therapeutics, Inc. (DRMA) is dated April 17, 2026. The proxy statement of Dermata Therapeutics, Inc. reports total compensation of $464,616 for Kyri K. Van Hoose in fiscal 2024, including a base salary of $328,500. Disclosed compensation is on record for 2 fiscal years. Dermata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dermata Therapeutics, Inc. includes Gerald T. Proehl (CEO and Board Member), Kyri Van Hoose (CFO), Andrew Sandler (Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 17, 2026
Company network
Leadership on record at Dermata Therapeutics, Inc.
- Gerald T. Proehl CEO, Board Member
- Kyri Van Hoose CFO
- Andrew Sandler Board Member
- Brittany Bradrick Board Member
- David Hale Board Member
- Kathleen Scott Board Member
- Steven Mento Board Member
- Steven Mento, Ph.D. Board Member
- To approve Board Member
- Wendell Wierenga Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Dermata Therapeutics, Inc. (DRMA) | Senior Vice President, Chief Financial Officer | $328,500 | $464,616 |
| 2023 | Dermata Therapeutics, Inc. (DRMA) | Senior Vice President, Chief Financial Officer | $315,000 | $442,250 |
Recent activity
No call appearances or filed executive changes recorded yet.